MktsMarkets

Cardiff Oncology, Inc.
NASDAQ: CRDFKey statistics
CRDF News
Stories mentioning CRDF from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 41.00 | 243.00 | 120.00 | 121.00 | 109.00 | 150.00 | 165.00 | 163.00 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 6,126 | 2,995 | 3,897 | 3,318 | 4,014 | 3,011 | 3,126 | 3,215 |
| Total Operating Expenses | 12,891 | 8,070 | 12,094 | 14,898 | 14,491 | 12,722 | 12,766 | 12,708 |
| Operating Income (Loss) | (12,850) | (7,827) | (11,974) | (14,777) | (14,382) | (12,572) | (12,601) | (12,545) |
| Interest Income | 506.00 | 612.00 | 716.00 | 835.00 | 941.00 | 787.00 | 741.00 | 805.00 |
| Interest Expense | ||||||||
| Other Expense | (1.00) | (1.00) | 0.00 | (1.00) | 7.00 | (2.00) | 5.00 | (38.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (12,345) | (7,216) | (11,258) | (13,943) | (13,434) | (11,787) | (11,855) | (11,778) |
| Earnings Per Share (Basic) | (0.18) | (0.11) | (0.17) | (0.21) | (0.20) | (0.25) | (0.25) | (0.26) |
| Earnings Per Share (Diluted) | (0.18) | (0.11) | (0.17) | (0.21) | (0.20) | (0.25) | (0.25) | (0.26) |
| Weighted Average Shares Outstanding (Basic) | 68,350 | 66,841 | 66,879 | 66,526 | 66,524 | 47,650 | 46,865 | 44,825 |
| Weighted Average Shares Outstanding (Diluted) | 68,350 | 66,841 | 66,879 | 66,526 | 66,524 | 47,650 | 46,865 | 44,825 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CRDF
Cardiff Oncology, Inc. (NASDAQ: CRDF) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRDF. It last traded at $0.8400 (Nov 18, 2026, 4:00 PM ET), down 0.9% on the day. That gives Cardiff Oncology a market capitalisation of $67.1M.
Over the past 52 weeks CRDF has traded between $0.7100 and $3.31.
Revenue for the quarter ended Mar 31, 2026 was $41.0K; a net loss of $12.3M. Revenue was down 62.4% from $109.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $41.0K | -$12.3M | -30109.8% |
| Dec 31, 2025 | $243.0K | -$7.2M | -2969.5% |
| Sep 30, 2025 | $120.0K | -$11.3M | -9381.7% |
| Jun 30, 2025 | $121.0K | -$13.9M | -11523.1% |
From Cardiff Oncology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…